What is the dosage of Valganciclovir? Correct medication method and dosage

Valganciclovir (English name Valganciclovir) is an antiviral drug mainly used to prevent and treat cytomegalovirus (CMV) infection, especially for immunosuppressed patients after organ transplantation or HIV infection. As the prodrug of ganciclovir, Vancevir is quickly converted into the active ingredient ganciclovir after digestion and absorption in the body, thereby exerting antiviral effects. In order to obtain the best effect, you must strictly follow the doctor's instructions to ensure that the dosage and method are accurate. The following is the detailed usage, dosage and medication precautions of Vancevi.

1. Standard usage and dosage for different indications

The dosage of Vancevir depends on the purpose of treatment (preventive or therapeutic), the patient's medical condition (such as kidney function), and weight and age. The following are recommended uses for several common indications:

1.For prevention of organ transplant patientsCMVinfection

For adults who have received an organ transplant (especially kidney, heart, or liver transplant patients), the recommended dosage is:

Take 900 mg orally once a day. It is recommended to start taking the medicine within 10 days after transplantation and continue until about 100 days after transplantation (or the treatment period recommended by the doctor). Some high-risk patients (such as donorsCMVpositive and recipientsCMVnegative) may need to be extended to 200 days.

2.For the treatment of active CMV retinitis (mainly seen in HIV infected persons)

At the beginning of treatment, the usually recommended dosage is:

Twice a day, 900 mg each time, for 21 days (induction period);

Then enter the maintenance treatment phase, taking 900mg orally once a day until the virus is effectively controlled or the drug is stopped according to the doctor's assessment.

3.Use in pediatric patients

For pediatric patients (e.g., transplant recipients), dosage is usually calculated based on body surface area (BSA) and renal function using a specific formula:

Dose (mg) = 7 × BSA × Renal function adjustment factor (based on creatinine clearance).

Doctors will adjust the dose based on each child's individual circumstances and recommend the use of oral suspension for precise dosing.

2. Instructions on medication time and method

Valganciclovir should be taken with food to enhance drug absorption and bioavailability, especially during high-dose treatment. When swallowing, take the tablet whole and do not crush or chew the tablet to avoid mucosal irritation or malabsorption. If oral suspension is used, a special measuring device should be used to measure the dose accurately and the bottle should be shaken well.

If the patient misses a dose, he should take it as soon as possible; if it is close to the time of the next dose, skip the missed dose and do not take double the dose. Random changes in dosage or discontinuation of medication should be avoided, and any dosage adjustments must be made under the guidance of a physician.

3. Dose adjustment for special groups

1.People with renal insufficiency

Valganciclovir is mainly excreted through the kidneys. In patients with renal insufficiency, the dose must be adjusted based on creatinine clearance (CrCl). For example, patients with a creatinine clearance of 40-59 ml/min may need to reduce their treatment dose to 450 mg twice daily.

2.Elderly patients

Since renal function may decline in the elderly, changes in renal function need to be closely monitored and the dose adjusted if necessary to avoid side effects such as bone marrow suppression caused by drug accumulation.

3. People with abnormal liver function

Although the liver is not the main metabolic pathway, patients with severe liver disease still need to use it with caution and check liver function indicators regularly during treatment.

4. Precautions and monitoring during medication

1. Blood system monitoring

Valganciclovir may cause leukopenia, anemia, or thrombocytopenia, especially when taken long-term or in combination with immunosuppressants. Therefore, during the medication period, it is recommended to conduct routine blood tests regularly and adjust the dose or suspend treatment if necessary.

2.Avoid combined use with other myelosuppressive drugs

If patients are taking anti-tumor drugs, immunosuppressive drugs (such as mycophenolate mofetil), etc., they need to pay special attention to drug interactions and adjust the dose or monitor toxic and side effects if necessary.

3.Use with caution during pregnancy and lactation

Valganciclovir has a potential teratogenic risk to the fetus in animal experiments, so its use during pregnancy is not recommended. If it is necessary to use it, you should make a careful decision after your doctor evaluates the risks. It is not clear whether the drug is excreted during lactation, so breastfeeding should be suspended during use.

4.Storage and Management

Tablets should be stored in a dry and cool place away from direct sunlight. The suspension should be kept in the refrigerator, shake well before use, and use within one month after preparation.

As an effective drug against cytomegalovirus, Vancevir has remarkable efficacy, but it also needs to be used strictly in accordance with the instructions of a doctor. Especially in the process of long-term prevention or treatment, attention should be paid to individualized dosage, regularity of medication, and monitoring of side effects, so as to minimize the risk of adverse reactions while controlling viral infection. If patients experience any discomfort while taking the medication, they should seek medical advice promptly and inform the doctor of their medication status so that reasonable adjustments can be made.

Reference materials:https://go.drugbank.com/drugs/DB01610